The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.